Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs
暂无分享,去创建一个
[1] D. Cantrell,et al. The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.
[2] I. Tannock,et al. Cell kinetics and chemotherapy: a critical review. , 1978, Cancer treatment reports.
[3] H. Mitsuya,et al. Strategies for antiviral therapy in AIDS , 1987, Nature.
[4] R. Baserga,et al. The Cell Cycle , 2007 .
[5] Marek Kimmel,et al. Estimation and prediction of cell cycle specific effects of anticancer drugs , 1986 .
[6] J. Deneubourg,et al. The effect of environmental disturbances on the dynamics of marine intertidal populations , 1985 .
[7] High-dose cytosine arabinoside therapy for refractory leukemia , 1983 .
[8] M. Minden,et al. Generation time of leukaemic blast progenitor cells. , 1983, Cell and tissue kinetics.
[9] F. Schabel. Concepts for systemic treatment of micrometastases , 1975, Cancer.
[10] M. Sundareshan,et al. On the Equivalence of Mathematical Models For Cell Proliferation Kinetics , 1984, Cell and tissue kinetics.
[11] A. Zhabotinsky,et al. Mathematical model of cancer chemotherapy. periodic schedules of phase-specific cytotoxic-agent administration increasing the selectivty of therapy , 1985 .
[12] Z. Agur,et al. The Effect of Drug Schedule on Responsiveness to Chemotherapy a , 1987 .